Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/66096
Type
ArticleCopyright
Restricted access
Collections
- IOC - Artigos de Periódicos [12980]
Metadata
Show full item record
BENIGN-BY-DESIGN SAHA ANALOGUES FOR HUMAN AND ANIMAL VECTOR-BORNE PARASITIC DISEASES
Green chemistry
One Health
Antiparasitic activity
Trypanosoma brucei brucei
Leishmania amazonensis
Author
Rossi, Michele
Martinengo, Bianca
Diamanti, Eleonora
Salerno, Alessandra
Rizzardi, Nicola
Fato, Romana
Bergamini, Christian
Oliveira, Andressa Souza de
Ferreira, Thais de Araújo Marques
Holanda, Cleonice Andrade
Romeiro, Luiz Antonio Soares
Soeiro, Maria de Nazaré Correia
Costa, Krislayne Nunes da
Fiuza, Ludmila Ferreira de Almeida
Batista, Marcos Meuser
Fraga, Carlos Alberto Manssour
Alkhalaf, Hamed E. A.
Elmahallawy, Ehab Kotb
Ebiloma, Godwin U.
De Koning, Harry P.
Vittorio, Serena
Vistoli, Giulio
Blanquart, Christophe
Bertrand, Philippe
Bolognesi, Maria Laura
Martinengo, Bianca
Diamanti, Eleonora
Salerno, Alessandra
Rizzardi, Nicola
Fato, Romana
Bergamini, Christian
Oliveira, Andressa Souza de
Ferreira, Thais de Araújo Marques
Holanda, Cleonice Andrade
Romeiro, Luiz Antonio Soares
Soeiro, Maria de Nazaré Correia
Costa, Krislayne Nunes da
Fiuza, Ludmila Ferreira de Almeida
Batista, Marcos Meuser
Fraga, Carlos Alberto Manssour
Alkhalaf, Hamed E. A.
Elmahallawy, Ehab Kotb
Ebiloma, Godwin U.
De Koning, Harry P.
Vittorio, Serena
Vistoli, Giulio
Blanquart, Christophe
Bertrand, Philippe
Bolognesi, Maria Laura
Affilliation
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
Universidade de Brasília. Faculdade de Medicina. Núcleo de Medicina Tropical. Laboratório de Desenvolvimento de Inovações Terapêuticas. Brasília, DF, Brasil.
Universidade de Brasília. Faculdade de Medicina. Núcleo de Medicina Tropical. Laboratório de Desenvolvimento de Inovações Terapêuticas. Brasília, DF, Brasil.
Universidade de Brasília. Faculdade de Medicina. Núcleo de Medicina Tropical. Laboratório de Desenvolvimento de Inovações Terapêuticas. Brasília, DF, Brasil.
Universidade de Brasília. Faculdade de Medicina. Núcleo de Medicina Tropical. Laboratório de Desenvolvimento de Inovações Terapêuticas. Brasília, DF, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Celular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Celular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Celular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Celular. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Ciências Biomédicas. Laboratório de Avaliação e Síntese de Substâncias Bioativas. Rio de Janeiro, RJ, Brasil.
University of Glasgow. College of Medical, Veterinary and Life Sciences. School of Infection and Immunity. Glasgow, United Kingdom.
Universidad de Córdoba. Facultad de Veterinaria. Grupo de Investigación en Sanidad Animal y Zoonosis. Departamento de Sanidad Animal. Córdoba, Spain / Sohag University. Faculty of Veterinary Medicine. Department of Zoonoses. Sohag, Egypt.
University of Salford. School of Science, Engineering & Environment. Manchester, United Kingdom.
University of Glasgow. College of Medical, Veterinary and Life Sciences. School of Infection and Immunity. Glasgow, United Kingdom.
University of Milan. Department of Pharmaceutical Sciences. Milan, Italy.
University of Milan. Department of Pharmaceutical Sciences. Milan, Italy.
Université d'Angers. CNRS UMR. Inserm UMR. Nantes Université. Nantes, France.
University of Poitiers. Poitiers, France.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
Universidade de Brasília. Faculdade de Medicina. Núcleo de Medicina Tropical. Laboratório de Desenvolvimento de Inovações Terapêuticas. Brasília, DF, Brasil.
Universidade de Brasília. Faculdade de Medicina. Núcleo de Medicina Tropical. Laboratório de Desenvolvimento de Inovações Terapêuticas. Brasília, DF, Brasil.
Universidade de Brasília. Faculdade de Medicina. Núcleo de Medicina Tropical. Laboratório de Desenvolvimento de Inovações Terapêuticas. Brasília, DF, Brasil.
Universidade de Brasília. Faculdade de Medicina. Núcleo de Medicina Tropical. Laboratório de Desenvolvimento de Inovações Terapêuticas. Brasília, DF, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Celular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Celular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Celular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Celular. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Ciências Biomédicas. Laboratório de Avaliação e Síntese de Substâncias Bioativas. Rio de Janeiro, RJ, Brasil.
University of Glasgow. College of Medical, Veterinary and Life Sciences. School of Infection and Immunity. Glasgow, United Kingdom.
Universidad de Córdoba. Facultad de Veterinaria. Grupo de Investigación en Sanidad Animal y Zoonosis. Departamento de Sanidad Animal. Córdoba, Spain / Sohag University. Faculty of Veterinary Medicine. Department of Zoonoses. Sohag, Egypt.
University of Salford. School of Science, Engineering & Environment. Manchester, United Kingdom.
University of Glasgow. College of Medical, Veterinary and Life Sciences. School of Infection and Immunity. Glasgow, United Kingdom.
University of Milan. Department of Pharmaceutical Sciences. Milan, Italy.
University of Milan. Department of Pharmaceutical Sciences. Milan, Italy.
Université d'Angers. CNRS UMR. Inserm UMR. Nantes Université. Nantes, France.
University of Poitiers. Poitiers, France.
University of Bologna. Alma Mater Studiorum. Department of Pharmacy and Biotechnology. Bologna, Italy.
Abstract
The search for new drugs fulfilling One Health and Green Chemistry requirements is an urgent call. Here, for the first time, we envisaged developing SAHA analogues by starting from the cashew nutshell liquid (CNSL) agro-industrial waste and employing a metathesis approach. This sustainable combination (comprising principles #7 and #9) allowed a straightforward synthesis of compounds 13–20. All of them were found to not be toxic on HepG2, IMR-32, and L929 cell lines. Then, their potential against major human and animal vector-borne parasitic diseases (VBPDs) was assessed. Compound 13 emerged as a green hit against the trypomastigote forms of T. b. brucei. In silico studies showed that the T. b. brucei HDAC (TbDAC) catalytic pocket could be occupied with a similar binding mode by both SAHA and 13, providing a putative explanation for its antiparasitic mechanism of action (13, EC₅₀ = 0.7 ± 0.2 μM).
Keywords
Cashew nutshell liquidGreen chemistry
One Health
Antiparasitic activity
Trypanosoma brucei brucei
Leishmania amazonensis
Share